US Broker Ratings

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unveiling a 109% Potential Upside for Investors

Cytokinetics, Incorporated (NASDAQ: CYTK) offers a captivating prospect for investors, with a substantial potential upside of 109.32% as per current analyst ratings. As a late-stage biopharmaceutical..

Masimo Corporation (MASI) Stock Analysis: A 9.65% Upside Potential in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, particularly in medical devices, presents a compelling case for investors looking for growth opportunities within..

Blueprint Medicines Corporation (BPMC) Stock Analysis: A Biotech Challenger with 55.5% Revenue Growth

Blueprint Medicines Corporation (NASDAQ: BPMC), a rising star in the biotechnology sector, is capturing investor attention with its robust revenue growth of 55.5%. Headquartered in Cambridge,..

RadNet, Inc. (RDNT) Stock Analysis: A Promising Prospect with 27% Potential Upside

RadNet, Inc. (NASDAQ: RDNT) stands as a formidable entity in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $4.22 billion, this..

GSK plc (GSK) Investment Outlook: Analyzing the 9.27% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as a pivotal player in the drug manufacturing industry, renowned for its robust portfolio of..

BrightSpring Health Services, I (BTSG) Investor Outlook: Anticipating a 27% Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, BrightSpring Health Services, Inc. (BTSG) presents a compelling case. Headquartered in Louisville, Kentucky, and operating in the Health..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 12.2% Upside Potential with Promising Pipeline in B-cell Treatments

TG Therapeutics, Inc. (NASDAQ: TGTX), a biotechnology company rooted in the healthcare sector, has caught the attention of investors with its innovative approach to treating B-cell..

Merck & Company, Inc. (MRK) Stock Analysis: Unpacking a 25.77% Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, renowned for its pioneering work in pharmaceuticals and animal health. With..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking a 24% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology industry, is currently capturing investor attention with its impressive 24.07% potential upside, as reflected in..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a Complex Landscape with High ROE and Growth Potential

Medpace Holdings, Inc. (NASDAQ: MEDP), a key player in the diagnostics and research sector, has carved out a significant niche within the healthcare industry. With a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 9.98% Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in San Juan..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Gem with 91% Potential Upside

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology industry, has been capturing investor attention with its robust pipeline and significant growth potential. Headquartered in..

Elanco Animal Health Incorporated (ELAN): Investor Outlook with a 1.53% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is making waves with..

Prestige Consumer Healthcare (PBH) Stock Analysis: Potential 10% Upside and Steady Revenue Growth for Savvy Investors

Prestige Consumer Healthcare Inc. (PBH), a notable player in the healthcare sector, specializes in the development, manufacturing, and marketing of over-the-counter (OTC) health and personal care..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking a 278% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (PCVX), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to innovative healthcare solutions. Specializing in the development..

Alkermes plc (ALKS) Stock Analysis: Analyst Consensus Points to 42% Upside Potential

Alkermes plc (NASDAQ: ALKS), an Irish biopharmaceutical giant, is capturing the attention of investors with a compelling narrative. Operating within the Healthcare sector, specifically among Drug..

Biogen Inc. (BIIB) Investor Outlook: Analyzing a 29.60% Potential Upside Amidst Strong Analyst Support

Biogen Inc. (NASDAQ: BIIB), a towering figure in the healthcare sector with a market cap of $19.47 billion, offers investors a compelling opportunity with a potential..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 27.08% Potential Upside in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is gaining attention from investors due to its promising growth prospects and robust position within..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 114% Potential Upside in the CAR-T Space

Legend Biotech Corporation (NASDAQ: LEGN) is positioned at the forefront of the biotechnology sector with its innovative focus on cell therapies for oncology. With a market..

Gilead Sciences, Inc. (GILD)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds